LD-2 disclosure · 4th Quarter - Report
STEALTH BIOTHERAPEUTICS INC.
via STEALTH BIOTHERAPEUTICS INC.
Expenses$40Kself-filed spend
Client
- Name
- STEALTH BIOTHERAPEUTICS INC.
- Description
- Developing therapies to treat mitochondrial dysfunction.
- Location
- Massachusetts · United States of America
Registrant
- Firm
- STEALTH BIOTHERAPEUTICS INC.
- Location
- Needham, Massachusetts, United States of America
Lobbying activities
1 issueHealth Issues
H.R. 7384/S. 4583, the Creating Hope Reauthorization Act of 2024 H.R. 4758/S. 2372, the Accelerating Kids Access to Care Act H.R. 3433, the Give Kids A Chance Act General discussions about ultra-rare disease drug development General discussions about regulatory reform, including scientific-focused drug development meetings H.R. 1092/S. 526, the BENEFIT Act General discussions about mitochondrial diseases H.R. 9979, the Scientific EXPERT Act of 2024 General discussions about ultra-rare diseases FDA Rare Disease Innovation Hub
Lobbyistsms KATHERINE LANDES
TargetedSENATE · HOUSE OF REPRESENTATIVES